Glucosamine Osteoarthritis Randomized Trial Evidence Table

Structured evidence table for Glucosamine Osteoarthritis Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Glucosamine Osteoarthritis Randomized TrialBackground Osteoarthritis is a common joint disease, especially among individuals aged 50 and older, leading to symptoms such as pain, stiffness, and functional limitations, particularly in weight-bearing joints like the knees.2Čeh T (2026)Complementary effect of a combined exercise and dietary supplement intervention in individuals with knee osteoarthritis: study protocol for a randomized, double-blind, placebo-controlled trial.
Glucosamine Osteoarthritis Randomized TrialKnee osteoarthritis (KOA) is increasingly prevalent, making effective treatment strategies critical.2Čeh T (2026)Complementary effect of a combined exercise and dietary supplement intervention in individuals with knee osteoarthritis: study protocol for a randomized, double-blind, placebo-controlled trial.
Glucosamine Osteoarthritis Randomized TrialBackground Large positive responses to placebo are common in clinical trials and pose a major challenge when evaluating different treatments, including new foods.2Motawei AM (2026)Using Dose-Response Correlation Re-Analyzing to Distinguish Placebo from Standardized Rose-Hip Powder (Lito) in a Clinical Trial on Osteoarthritis Where Data Initially Looked Identical.
Glucosamine Osteoarthritis Randomized TrialStandard between-group comparisons may fail to detect true effects when placebo improvements are significant.2Motawei AM (2026)Using Dose-Response Correlation Re-Analyzing to Distinguish Placebo from Standardized Rose-Hip Powder (Lito) in a Clinical Trial on Osteoarthritis Where Data Initially Looked Identical.

Source documents

  1. Complementary effect of a combined exercise and dietary supplement intervention in individuals with knee osteoarthritis: study protocol for a randomized, double-blind, placebo-controlled trial.
  2. Using Dose-Response Correlation Re-Analyzing to Distinguish Placebo from Standardized Rose-Hip Powder (Lito) in a Clinical Trial on Osteoarthritis Where Data Initially Looked Identical.